Ose Immunotherapeutics To Present New Clinical And Preclinical Data At The Society For Immunotherapy Of Cancer (sitc) 36th Annual Meeting

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Data on Tedopi®, BiCKI® and CLEC-1 programs being presented in three poster presentations – November 12 - 14, 2021NANTES, France, Oct. 13, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: ... read more

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

OSE) announces that three abstracts have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 36 th Annual Meeting in Washington D.C. (and virtually) held on November 10 – ... read more

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

NANTES, France, Oct. 13, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics ... for presentation at the Society for Immunotherapy of Cancer (SITC) 36 th Annual Meeting in Washington D.C. (and ... read more

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Data on Tedopi®, BiCKI® and CLEC-1 programs being presented in three poster presentations – November 12 - 14, 2021 NANTES, France, October 13, 2021--(BUSINESS WIRE)--Regulatory News: OSE ... read more

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

In Phase 2 in pancreatic cancer (TEDOPaM), sponsor ... information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2021, including the ... read more

OSE Immunotherapeutics to Present New Clinical and Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

In Phase 2 in pancreatic cancer (TEDOPaM ... be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on 15 April 2021, including the annual financial report ... read more

Related Blogs:

Cancer Immunotherapeutics Annual France November





Real Time RSS Feeds | Disclaimer | Contact Us